Celebrating the discovery of mutated CALR
MPN Research Foundation is proud to celebrate the 10-year anniversary of the identification of CALR as a common driver of MPNs. We funded early work that discovered this MPN driver mutation. Learn more >
MPNRF by the numbers
Total donated dollars
invested in research
$ 0 M
Researchers supported
0
Countries with
supported research
0
Projects funded
0

What is
essential
thrombocythemia
(ET)?

Essential Thrombocythemia (ET)

Most commonly diagnosed in women over the age of 50, ET is associated with a proliferation of platelet precursors in the bone marrow and complications frequently include blood clotting and/or bleeding.

Learn more about ET

What is
polycythemia vera
(PV)?

Polycythemia vera (PV)

The disease is most common in men over the age of 60, but anyone can develop PV. PV patients typically experience an elevated red blood cell count, an elevated platelet count and an enlarged spleen, especially over time.

Learn more about PV

What is
myelofibrosis
(MF)?

Myelofibrosis (MF)

MF is a chronic blood cancer in which excessive scar tissue forms in the bone marrow and impairs its ability to produce normal blood cells.

Learn more about MF
Patients, clinicians, researchers, and the biotech and pharma industries all have critical roles to play in advancing MPN research and are all important members of the MPNRF community.
Connect with us to be part of our coordinated effort to find new treatments — and eventually cures — for MPNs.

Patients
and Caregivers

Every patient experience is unique and provides new clues for researchers and clinicians.

SHARE YOUR STORY
CLINICAL TRIAL FINDER

Researchers
and
Clinicians

In our 24-year history, MPNRF has contributed to some of the most influential MPN research discoveries.

CLINICIAN RESOURCES
APPLY FOR FUNDING

Industry
and
Biopharma

Engage with us to ensure that new therapies have the maximum impact on patient outcomes and quality of life.

MPN ROUNDTABLE™

Download our Voice of the Patient report

DOWNLOAD

Ready to do more?

Julie and her family joined team MPN and created HikeMF to join the fight against MPNs.

GET INVOLVED NOW

Stay connected

Invest in MPN research

Your investment supports doctors and researchers around the world who are dedicated to finding cures for MPNs.

 INVEST NOW

Join the community
Be the first to know about the latest news and advancements for ET, PV, and MF. Sign up to receive our newsletters and alerts.
SUBSCRIBE TODAY

Recent news

  • MPN Pathways: Empowered Voices in Research Bonus Session Summary — What’s Your Why?

    MPN NEWS | April 25, 2025

    MPN Pathways: Empowered Voices in Research bonus session — What’s your why? At MPN Research Foundation, we are dedicated to ensuring that the patient’s voice is at the forefront of our work. As we grow in our role as a patient-centered research foundation, we continue to take intentional steps to bridge the intersection of patients,… Read More »MPN Pathways: Empowered Voices in Research Bonus Session Summary — What’s Your Why?

    READ MORE

    Hematologist discovers the kidneys: One researcher’s quest to explain an overlooked MPN complication  

    MPN NEWS | April 25, 2025

    Profile: Brandi Reeves, MDUniversity of North Caroline at Chapel Hill Hematologist discovers the kidneys: One researcher’s quest to explain an overlooked MPN complication   It all started with a series of patients who couldn’t qualify for a clinical trial. Not for lack of interest — one after another, patients with myeloproliferative neoplasms (MPNs) couldn’t meet enrollment criteria.… Read More »Hematologist discovers the kidneys: One researcher’s quest to explain an overlooked MPN complication  

    READ MORE

    Dr. Simón Méndez-Ferrer Research Profile

    MPN NEWS | March 20, 2025

    Profile: Simón Méndez-Ferrer, PhDRutgers University Beyond mutant cells: Dr. Simón Méndez-Ferrer on the role of the bone marrow environment in myelofibrosis (MF). In a healthy body, the bone marrow is a bustling ecosystem, teeming with diverse cellular species, each playing a supportive role and maintaining balance. Stem cells stand at the heart of this environment,… Read More »Dr. Simón Méndez-Ferrer Research Profile

    READ MORE